Cymbalta Sales Data

Rank 7 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Cymbalta U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 7 (3) -23.06% -25.41%
Q3 2013 4 3.31% -7.81%
Q2 2013 4 (1) 3.24% 2.77%
Q1 2013 3 (1) 5.65% -2.09%
Q4 2012 4 5.97% 4.07%
Q3 2012 4 (2) 9.50% 2.34%
Q2 2012 6 (2) 2.77% 2.20%
Q1 2012 8 (1) 7.58% 0.66%
Q4 2011 9 4.70% 3.47%
Q3 2011 9 (3) 6.08% -1.53%
Q2 2011 12 (2) 5.03% 4.46%
Q1 2011 10

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
December 12, 2013Health Highlights: Dec. 12, 2013
December 12, 2013FDA Approves First Generic Versions of Cymbalta
December 11, 2013Generic Cymbalta Approved
November 5, 2010Cymbalta Approved for Chronic Joint and Muscle Pain
August 18, 2010Lilly Pursues OK for Cymbalta for Chronic Pain
November 24, 2008Study Calls for Greater Scrutiny of 'Off-Label' Drug Use
August 25, 2008Patients Taking Cymbalta Experienced Reduced Chronic Low Back Pain in New Study
Hide
(web5)